Cleared Traditional

K110212 - INRATIO2 PI/NR MONITORING SYSTEM

Also marketed or referenced as:
INRATIO PT/INR TEST STRIP

K110212 is the FDA 510(k) clearance for INRATIO2 PI/NR MONITORING SYSTEM by Alere San Diego, Inc (Formally Biosite Incorporate. It is a Class 2 Hematology device (product code GJS) cleared through the Traditional 510(k) pathway after a 462-day FDA review.

K110212 · Alere San Diego, Inc (Formally Biosite Incorporate · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2012
Decision
462d
Days
Class 2
Risk

K110212 is an FDA 510(k) clearance for the INRATIO2 PI/NR MONITORING SYSTEM. Classified as Test, Time, Prothrombin (product code GJS), Class II - Special Controls.

Submitted by Alere San Diego, Inc (Formally Biosite Incorporate (San Diego, US). The FDA issued a Cleared decision on May 1, 2012 after a review of 462 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7750 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Hematology submissions.

View all Alere San Diego, Inc (Formally Biosite Incorporate devices

Submission Details

510(k) Number K110212 FDA.gov
FDA Decision Cleared Substantially Equivalent - Abbreviated 510(k) (SESU)
Date Received January 25, 2011
Decision Date May 01, 2012
Days to Decision 462 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
349d slower than avg
Panel avg: 113d · This submission: 462d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GJS Test, Time, Prothrombin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GJS Test, Time, Prothrombin

All 95
Devices cleared under the same product code (GJS) and FDA review panel - the closest regulatory comparables to K110212.
Xprecia Stride Coagulation System, Xprecia System PT Controls
K151964 · Siemens Healthcare Diagnostics · Sep 2016
HEMOSIL RECOMBIPLASTIN 2G (8 ML VIAL)
K132722 · Instrumentation Laboratory CO · Jan 2014
HEMOSIL READIPLAS TIN
K122584 · Instrumentation Laboratory CO · Mar 2013
INRATIO/INRATIO2 TEST STRIPS
K092987 · Biosite Incorporated · Jun 2010
COAGUCHEK XS PRO SYSTEM
K093460 · Roche Diagnostics · Mar 2010
COAGUCHEK XS PLUS PST SYSTEM
K092940 · Roche Diagnostics Corp. · Mar 2010